Skip to main content
Stephen Kimani
( out of 92 reviews )

Stephen Kimani, MD, MSc

Languages spoken: English, Swahili
  • Specialties

    Board Certification

    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Hematology)
    American Board of Internal Medicine (Sub: Medical Oncology)
    Educational Commission for Foreign Medical Graduates

    Patient Rating

    5.0 /5
    ( out of 92 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    February 23, 2024

    We were thoroughly impressed with Dr. Kimani and his team.

    January 29, 2024

    Dr. Kimani and nurse Tammy are amazing!!

    January 21, 2024

    Dr. Kimani is very professional and cares a great deal about his patients. He is friendly, knowledgeable and very thorough.

    January 16, 2024

    Dr Kimani is great. He addresses concerns clearly, and is very personable and professional

    December 20, 2023

    Dr Kimami is very professional, he displays genuine concern for you as a person never makes you feel he is in a hurry patiently answer your questions.

    December 16, 2023

    I am so grateful for Dr. Kimani. I am just at the beginning of a very scary process and I feel very confident I am receiving the best care possible by Dr. Kimani and his team.

    December 13, 2023

    Outstanding doctor! He takes time to listen and explain. I appreciate him so much.

    October 19, 2023

    Loved him. So great and caring. Loved his NP Tammy as well

    October 19, 2023

    I had a wonderful experience during my recent visit with Dr. Kimani From the moment I walked into the clinic, the staff was attentive and friendly, making me feel comfortable and at ease. Dr. Kimani was not only knowledgeable but also took the time to attentively listen to my concerns and questions. Their explanations were clear, and he made sure I fully understood the diagnosis and treatment options. I left the appointment feeling confident in the care I received, and I highly recommend Dr. Kimani to anyone seeking an ovarian specialist.

  • Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions Oncology
    Board Certification
    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Hematology)
    American Board of Internal Medicine (Sub: Medical Oncology)
    Educational Commission for Foreign Medical Graduates

    Education history

    Fellowship Global Oncology - Fogarty International Center, National Institutes of Health Postdoctoral Fellow
    Hematology/Oncology - University of North Carolina School of Medicine Fellow
    Residency Internal Medicine - Duke University School of Medicine Resident
    Internal Medicine - Duke University School of Medicine Intern
    Graduate Training Global Health - Duke University M.Sc.
    Medicine - University of Nairobi M.B.Ch.B.
    Undergraduate Human Anatomy - University of Nairobi B.Sc. (Hons)

    Selected Publications

    Journal Article

    1. Knettel B, Minja L, Msoka E, Tarimo C, Katiti V, Pan W, Mwobobia J, Juhlin E, Knippler E, Watt M, Suneja G, Kimani S, Abouelella D, Mmbaga B, Osazuwa-Peters N (2023). Culturally-informed adaptation and psychometric properties of the Cataldo Cancer Stigma Scale in Northern Tanzania. J Psychosoc Oncol, 1-13. (Read full article)
    2. Watt MH, Suneja G, Zimba C, Westmoreland KD, Bula A, Cutler L, Khatri A, Painschab MS, Kimani S (2023). Cancer-Related Stigma in Malawi: Narratives of Cancer Survivors. JCO Glob Oncol, 9, e2200307. (Read full article)
    3. Gondwe Y, Kudowa E, Tomoka T, Kasonkanji ED, Kaimila B, Zuze T, Mumba N, Kimani S, Mulenga M, Chimzimu F, Kampani C, Randall C, Lilly A, Gopal S, Fedoriw Y, Painschab M (2022). Comparison of baseline lymphoma and HIV characteristics in Malawi before and after implementation of universal antiretroviral therapy. PLoS One, 17(9), e0273408. (Read full article)
    4. Kasonkanji E, Kimani S, Skiver B, Ellis G, Seguin R, Kaimila B, Tomoka T, Mulenga M, Montgomery N, Fedoriw Y, Gopal S, Westmorland KD, Painschab MS (2022). Clinical Characteristics and Outcomes of Acute Lymphoblastic Leukemia in Adolescents and Young Adults in Malawi. *First Authors. JCO Glob Oncol, 8, e2100388. (Read full article)
    5. Martin RL 3rd, Grant MJ, Kimani S, Midha S, May J, Patell R, Collier E, Furfaro D, Bodine C, Reap L, Shah N, DeLaune J, Brusca S, Olazagasti C, Goyal S, Rubinstein S, Hakim N, Qin S, Browning SL, Sena L, Gilbert J, Davidson M, Lovly CM, Seetharamu N, Rangachari D, Murphy M, Chatwal M, Paschal R, Henry E, Collichio F, Green JR (2021). Forming the Hematology-Oncology Collaborative Videoconferencing (CO-VID) Learning Initiative: Experiential Lessons Learned From a Novel Trainee-Led Multidisciplinary Virtual Learning Platform. JCO Oncol Pract, 18(1), e36-e46. (Read full article)
    6. Painschab MS, Kohler R, Kimani S, Mhango W, Kaimila B, Zuze T, Mithi V, Kasonkanji E, Mumba N, Nyasosela R, Wheeler S, Gopal S (2021). Comparison of best supportive care, CHOP, or R-CHOP for treatment of diffuse large B-cell lymphoma in Malawi: a cost-effectiveness analysis. Lancet Glob Health, 9(9), e1305-e1313. (Read full article)
    7. Kimani S, Painschab MS, Kaimila B, Kasonkanji E, Zuze T, Tomoka T, Mulenga M, Nyasosela R, Chikasema M, Mtangwanika A, Chawinga M, Mhango W, Nicholas S, Chimzimu F, Kampani C, Krysiak R, Lilly A, Randall C, Seguin R, Westmoreland KD, Montgomery ND, Fedoriw Y, Gopal S (2021). Safety and efficacy of rituximab in patients with diffuse large B-cell lymphoma in Malawi: a prospective, single-arm, non-randomised phase 1/2 clinical trial. Lancet Glob Health, 9(7), e1008-e1016. (Read full article)
    8. Kedar Mukthinuthalapati VVP, Sewram V, Ndlovu N, Kimani S, Abdelaziz AO, Chiao EY, Abou-Alfa GK (2021). Hepatocellular Carcinoma in Sub-Saharan Africa. JCO Glob Oncol, 7, 756-766. (Read full article)
    9. Ellis GK, Manda A, Topazian H, Stanley CC, Seguin R, Minnick CE, Tewete B, Mtangwanika A, Chawinga M, Chiyoyola S, Chikasema M, Salima A, Kimani S, Kasonkanji E, Mithi V, Kaimila B, Painschab MS, Gopal S, Westmoreland KD (2020). Feasibility of upfront mobile money transfers for transportation reimbursement to promote retention among patients receiving lymphoma treatment in Malawi. Int Health, 13, 297-304. (Read full article)
    10. Kimani SM, Painschab MS, Horner MJ, Muchengeti M, Fedoriw Y, Shiels MS, Gopal S (2020). Epidemiology of haematological malignancies in people living with HIV. Lancet HIV, 7(9), e641-e651. (Read full article)
    11. Watt MH, Kimani SM, Skinner D, Meade CS (2015). "Nothing Is Free": A Qualitative Study of Sex Trading Among Methamphetamine Users in Cape Town, South Africa. Arch Sex Behav, 45(4), 923-33. (Read full article)
    12. Ramadhani HO, Bartlett JA, Thielman NM, Pence BW, Kimani SM, Maro VP, Mwako MS, Masaki LJ, Mmbando CE, Minja MG, Lirhunde ES, Miller WC (2016). The Effect of Switching to Second-Line Antiretroviral Therapy on the Risk of Opportunistic Infections Among Patients Infected With Human Immunodeficiency Virus in Northern Tanzania. Open Forum Infect Dis, 3(1), ofw018. (Read full article)
    13. Meade CS, Towe SL, Watt MH, Lion RR, Myers B, Skinner D, Kimani S, Pieterse D (2015). Addiction and treatment experiences among active methamphetamine users recruited from a township community in Cape Town, South Africa: A mixed-methods study. Drug Alcohol Depend, 152, 79-86. (Read full article)
    14. Meade CS, Towe SL, Watt MH, Hobkirk AL, Skinner D, Myers B, Kimani SM, Pieterse D (2014). HIV testing behaviors and attitudes among community recruited methamphetamine users in a South African township. AIDS Behav, 19(1), 186-91. (Read full article)
    15. Kimani SM, Watt MH, Merli MG, Skinner D, Myers B, Pieterse D, MacFarlane JC, Meade CS (2014). Respondent driven sampling is an effective method for engaging methamphetamine users in HIV prevention research in South Africa. Drug Alcohol Depend, 143, 134-40. (Read full article)
    16. Ramadhani HO, Bartlett JA, Thielman NM, Pence BW, Kimani SM, Maro VP, Mwako MS, Masaki LJ, Mmbando CE, Minja MG, Lirhunde ES, Miller WC (2014). Association of first-line and second-line antiretroviral therapy adherence. Open Forum Infect Dis, 1(2), ofu079. (Read full article)
    17. Watt MH, Meade CS, Kimani S, MacFarlane JC, Choi KW, Skinner D, Pieterse D, Kalichman SC, Sikkema KJ (2013). The impact of methamphetamine ("tik") on a peri-urban community in Cape Town, South Africa. Int J Drug Policy, 25(2), 219-25. (Read full article)


    1. Fenlon JB, Rositch AF, Dickey BL, Kimani S, Suneja G (2021). Gynecological radiotherapy in people living with human immunodeficiency virus: a semi-systematic literature review. [Review]. Int J Gynecol Cancer, 32(3), 429-435. (Read full article)


    1. Patell R, Midha S, Kimani S, Martin R, Neparidze N, Jaglal M, Freed J, Key NS (2020). Variability in Institutional Guidance for COVID-19-Associated Coagulopathy in the United States. [Letter to the editor]. Thromb Haemost, 120(12), 1725-1732. (Read full article)


    1. Reid E, Suneja G, Al-Rohil R, Alexiev B, Ambinder RF, Ard K, Baiocchi R, Campbell T, Carchman E, Dickson E, Eschenauer G, Goyal G, Gupta NK, Henry DH, Jones A, Kimani S, Klopp A, LaCasce AS, Lin C, Maurer T, Menon MP, Morgan D, Nathwani N, Palm D, Paragh G, Park HS, Ratner L, Rizza S, Sanchez J, Schorge J, Timmerman J, Wang CJ, Freedman-Cass D, Nguyen J, Schonfeld R (2023). NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Cancer in People with HIV 1.2024. Accessed 11/07/23.  To view the most recent and complete version of the guideline, go online to
  • News & Podcasts